SEARCH

SEARCH BY CITATION

References

  • 1
    Hong JC, Kahan BD. Immunosuppressive agents in organ transplantation: Past, present, and future. Semin Nephrol 2000; 20: 108125.
  • 2
    Monsour HP, Jr., Wood RP, Dyer CH, Galati JS, Ozaki CF, Clark JH. Renal insufficiency and hypertension as long-term complications in liver transplantation. Semin Liver Dis 1995; 15: 123132.
  • 3
    Platz KP, Mueller AR, Blumhardt G, et al. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. Transpl Int 1994; 7(Suppl 1): S52S57.
  • 4
    Wiesner R, Klintmalm G, McDiarmid S, Rapamune Liver Transplant Study Group Sirolimus immunotherapy results in reduced rates of acute rejection in de novo orthotopic liver transplant recipients [abstract 1294]. Am J Transplant 2002; 2: 464.
  • 5
    Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment. Transplantation 2001; 72: 19341939.
  • 6
    Di Benedetto F, Di SS, De RN, et al. Immunosuppressive switch to sirolimus in renal dysfunction after liver transplantation. Transplant Proc 2009; 41: 12971299.
  • 7
    Di Benedetto F, Di SS, De RN, et al. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors. J Clin Gastroenterol 2009; 43: 280286.
  • 8
    Schena FP, Pascoe MD, Alberu J, et al. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation 2009; 87: 233242.
  • 9
    Cotterell AH, Fisher RA, King AL, et al. Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent. Clin Transplant 2002; 16(Suppl 7): 4951.
  • 10
    Fairbanks KD, Eustace JA, Fine D, Thuluvath PJ. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Liver Transpl 2003; 9: 10791085.
  • 11
    Heffron TG, Smallwood GA, Davis L, Martinez E, Stieber AC. Sirolimus-based immunosuppressive [correction of immunosuppresive] protocol for calcineurin sparing in liver transplantation. Transplant Proc 2002; 34: 15221523.
  • 12
    Nair S, Eason J, Loss G. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients. Liver Transpl 2003; 9: 126129.
  • 13
    Neff GW, Montalbano M, Slapak-Green G, et al. Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. Transplant Proc 2003; 35: 30293031.
  • 14
    Sanchez EQ, Martin AP, Ikegami T, et al. Sirolimus conversion after liver transplantation: improvement in measured glomerular filtration rate after 2 years. Transplant Proc 2005; 37: 44164423.
  • 15
    Wadei HM, Mai M, Ahsan N, Rosser BG, Gonwa TA. High risk of proteinuria and lack of improvement of kidney function following sirolimus conversion in liver transplant recipients [abstract 1370]. Am J Transplant 2008; 8: 543.
  • 16
    Shaikh TA, Sterling RK, Shiffman ML, Fisher RA, Cotterell AH, Maluf DG. Adverse effects and poor tolerance of sirolimus (SIR) in liver transplant recipients [abstract 480]. Am J Transplant 2008; 2(Suppl 2): 307.
  • 17
    Shenoy S, Hardinger KL, Crippin J, et al. Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial. Transplantation 2007; 83: 13891392.
  • 18
    Watson CJ, Gimson AE, Alexander GJ, et al. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 2007; 13: 16941702.
  • 19
    Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 3141.
  • 20
    Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931940.
  • 21
    Sanchez EQ, Melton LB, Chinnakotla S, et al. Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation 2010; 89: 232235.
  • 22
    Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 301309.